RRAS2 and astrocytoma (excluding glioblastoma): Moreover, R-RAS2 overexpression is also more pronounced in lower grade tumors than in high-grade glioblastomas, astrocytomas and oligodendrogliomas (Figure 1, Additional file 1: Figure S1a and Additional file 2: Figure S3).